Emile Voest
Director/Board Member bij SANOFI
Profiel
Emile Voest is the founder of the Hartwig Medical Foundation, founded in 2015, where he holds the title of Non-Executive Director.
He was also the founder of the Hubrecht Organoid Technology Foundation, founded in 2013, where he held the title of Medical Director from 2013 to 2016.
Additionally, Dr. Voest is the founder of the Center For Personalized Cancer Therapy, founded in 2010, where he currently serves as Director.
Dr. Voest's current job(s) include being an Independent Director at Sanofi since 2022 and a Professor at the University of Utrecht since 1999.
Dr. Voest's former job(s) include being the Director of the European Society for Medical Oncology from 2015 to 2020 and the Executive Medical Director of Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh from 2014 to 2020.
Dr. Voest obtained a doctorate degree from the University of Utrecht.
Actieve functies van Emile Voest
| Bedrijven | Functie | Begin |
|---|---|---|
| SANOFI | Director/Board Member | 03-05-2022 |
| Hartwig Medical Foundation | Founder | 01-01-2015 |
| Center For Personalized Cancer Therapy | Founder | 01-01-2010 |
| University of Utrecht | Corporate Officer/Principal | 01-01-1999 |
Eerdere bekende functies van Emile Voest
| Bedrijven | Functie | Einde |
|---|---|---|
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
 Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands. | Chief Tech/Sci/R&D Officer | 01-01-2020 |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Director/Board Member | 01-01-2020 |
| Hubrecht Organoid Technology Foundation | Founder | 01-01-2016 |
Opleiding van Emile Voest
| University of Utrecht | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SANOFI | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Health Services |
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands. | Miscellaneous |
| Hubrecht Organoid Technology Foundation | |
| Hartwig Medical Foundation | |
| Center For Personalized Cancer Therapy |
